TAI'AN CITY, China, Aug. 28 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (CBPO.PK), one of leading plasma-based pharmaceutical company in the People's Republic of China (“PRC”), today announced that its Chief Executive Officer, Stanley Wong will present at the upcoming Roth Capital Partners 2007 New York Conference (the “Roth Conference”) on Wednesday, September 5, 2007.
The Roth Capital Partners Conference features presentations from more than 230 small- and micro-cap companies with a focus on undiscovered companies as well as international companies that aren't well known to U.S. investors in the technology, healthcare, financial services and consumer products sectors. The date, time and location of China Biologic's presentation at the Roth Conference are as follows:
Date: Wednesday, September 5, 2007
Time: 4:30 p.m. Eastern Time
Venue: The Westin Times Square Hotel, New York
Interested parties and institutional investors may register for the conference by visiting the conference website at http://www.rothconference.com/ or by calling Roth Capital Partners at (800) 678-9147.
About China Biologic Products, Inc.
China Biologic Products, Inc., is a rapid growing biopharmaceutical company, engaging in the research, production, and manufacture of plasma-based pharmaceutical products in China. Its products include human albumin and various immunoglobulins. Its brand "Lu Yue" enjoys great reputation nationwide. CBPO has strong R&D team and became one of the enterprises that first received the "Certificate of Good Manufacturing Practices (GMP) for Pharmaceutical Products" issued by SDA of PRC. For more information, contact CCG Elite directly or visit China Biologic's website at http://www.ctbb.com.cn .
For more information, please contact:
Crocker Coulson, President
Gary Chin, Financial Writer
CCG Elite
Tel: +1-646-213-1915
Email: crocker.coulson@ccgir.com
Stanley Wong, Chief Executive Officer
China Biologic Products Inc.
Tel: +86-538-6202608